533P Efficacy and safety of entrectinib in patients with locally advanced/metastatic NTRK fusion-positive (NTRK-fp) solid tumours.

Saved in:
Bibliographic Details
Title: 533P Efficacy and safety of entrectinib in patients with locally advanced/metastatic NTRK fusion-positive (NTRK-fp) solid tumours.
Authors: Bazhenova, L.1 (AUTHOR), Liu, S.V.2 (AUTHOR), Lin, J.J.3 (AUTHOR), Lu, S.4 (AUTHOR), Drilon, A.5 (AUTHOR), Chawla, S.P.6 (AUTHOR), Fakih, M.7 (AUTHOR), Krzakowski, M.8 (AUTHOR), Paz-Ares, L.9 (AUTHOR), Blakely, C.10 (AUTHOR), Buchschacher, G.L.11 (AUTHOR), Cassier, P.12 (AUTHOR), Fan, Y.13 (AUTHOR), Folprecht, G.14 (AUTHOR), McCallum, S.15 (AUTHOR), Pitcher, B.16 (AUTHOR), Chen, D.17 (AUTHOR), Freund, R.18 (AUTHOR), Springfeld, C.19 (AUTHOR)
Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS598-S599. 2p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first